Medical Decision Making

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

SAGETRACK

Sign In to gain access to subscriptions and/or personal tools.
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (6)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dunn, A. S.
Right arrow Articles by Sacks, H. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dunn, A. S.
Right arrow Articles by Sacks, H. S.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Medical Decision Making, Vol. 25, No. 4, 387-397 (2005)
DOI: 10.1177/0272989X05278432

Perioperative Management of Patients on Oral Anticoagulants: A Decision Analysis

Andrew S. Dunn, MD, FACP

Division of General Medicine, Department of Medicine, Mount Sinai School of Medicine, New York, New York, andrew.dunn{at}mountsinai.org

Juan Wisnivesky, MD

Division of General Medicine, Department of Medicine, Mount Sinai School of Medicine, New York, New York

Warren Ho, MD

Division of General Medicine, Department of Medicine, Mount Sinai School of Medicine, New York, New York

Carlton Moore, MD

Division of General Medicine, Department of Medicine, Mount Sinai School of Medicine, New York, New York

Thomas McGinn, MD, MPH

Division of General Medicine, Department of Medicine, Mount Sinai School of Medicine, New York, New York

Henry S. Sacks, MD, PhD

Departments of Community and Preventive Medicine, Medicine and Biomathematical Sciences, Mount Sinai School of Medicine, New York, New York

Background. To better inform clinicians on the optimal management of patients on oral anticoagulation who need to undergo surgery or invasive procedures, the authors performed a decision analysis examining whether a perioperative aggressive or minimalist strategy results in greater quality-adjusted survival.Methods. A decision analysis model was created comparing withholding warfarin (minimalist strategy) to withholding warfarin and administering treatment-dose subcutaneous low-molecular-weight heparin (LMWH) or intravenous heparin perioperatively (aggressive strategy). The base-case analysis examined a hypothetical 60-year-old hypertensive individual with mechanical aortic valve replacement undergoing major abdominal surgery. A probabilistic sensitivity analysis was performed using a Monte Carlo simulation with quality-adjusted life expectancy (QALE) as the outcome. Secondary analyses examined patients with a mechanical mitral valve and atrial fibrillation. Sensitivity analyses were performed for each variable.Results. Under the base-case scenario, the minimalist strategy was preferred for 78% of trials in the Monte Carlo simulation, with a mean benefit of 0.003 years (95% confidence interval, -0.005 years to 0.011 years). Sensitivity analyses based on point estimates indicate that the aggressive strategy is preferred when the annual stroke rate is >5.6% or the increase in postoperative major bleeding induced by heparin is <2.0%; however, the benefit is small over the range of plausible values.Conclusions. For most patients with a mechanical aortic valve or atrial fibrillation undergoing major surgery, a minimalist strategy of simply withholding oral anticoagulation provides similar QALE as an aggressive strategy of administering perioperative subcutaneous LMWH or intravenous heparin. The aggressive therapy provides greater QALE for patients at higher risk of stroke (e.g., mechanical mitral valves), although the benefit is small.

Key Words: surgery • anticoagulation • decision analysis • mechanical heart valves • atrial fibrillation • stroke


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
NEJMHome page
M. Selim
Perioperative Stroke
N. Engl. J. Med., February 15, 2007; 356(7): 706 - 713.
[Full Text] [PDF]


Home page
Med Decis MakingHome page
M. H. Eckman
"Bridging On the River Kwai": The Perioperative Management of Anticoagulation Therapy
Med Decis Making, July 1, 2005; 25(4): 370 - 373.
[PDF]